Lattice corneal dystrophy type II: Clinical, pathologic, and molecular study in a Spanish family

European Journal of Ophthalmology

Volumn 17, Issue 3, 2007, Pages 424-429

  Huerva, V ^a,b   Velasco, A ^a   Sanchez M C ^a   Mateo, A J ^a   Matias Guiu X ^a  

^a HOSPITAL ARNAU DE VILANOVA   (Spain)

^b NONE   (Spain)

Author keywords

Amyloidosis type V; Corneal lattice dystrophy type II; Gelsolin; Meretoja syndrome; Mutation

Indexed keywords

ALCOHOL; CONGO RED; DIAMINOBENZIDINE; DNA; EOSIN; EPOXY RESIN; FORMALDEHYDE; GELSOLIN; GLUTARALDEHYDE; HEMATOXYLIN; NUCLEOTIDE; PARAFFIN; PROTEIN S 100; XYLENE; AMYLOID;

AGED; ANAMNESIS; ARTICLE; BLURRED VISION; BOWMAN MEMBRANE; CASE REPORT; CLINICAL FEATURE; CORNEA DYSTROPHY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DNA DETERMINATION; ELECTRON MICROSCOPY; EYELID RECONSTRUCTION; FAMILIAL AMYLOIDOSIS; FEMALE; GENE IDENTIFICATION; GENE MUTATION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; PHACOEMULSIFICATION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SPAIN; CONGENITAL CORNEA DYSTROPHY; EXON; GENETICS; MALE; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PEDIGREE; POINT MUTATION; POLYMERASE CHAIN REACTION; SYNDROME;

AGED; AMYLOID; AMYLOIDOSIS, FAMILIAL; BLEPHAROPLASTY; CORNEAL DYSTROPHIES, HEREDITARY; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GELSOLIN; HUMANS; MALE; PEDIGREE; POINT MUTATION; POLYMERASE CHAIN REACTION; SPAIN; SYNDROME;

EID: 34447116987     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210701700326     Document Type: Article

References (21)

1. Barraquer RI, de Toledo MC, Torres E. Distrofias y Degeneraciones Corneales. Barcelona: Espaxs, 2004; 141-9.
2. De Sousa LB, Mannis MJ. The stromal dystrophies. In: Krachmer JH, Mannis MJ, Holland EJ, eds. Cornea. Fundamentals, Diagnosis and Management. Vol. 1. Philadelphia: Elsevier Mosby; 2005: 907-27.
3. Meretoja J. Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes, and various internal symptoms: a previously unrecognized heritable syndrome. Ann Clin Res 1969; 1: 314-24.
4. Donders PC, Blanksma LJ. Meretoja syndrome. Lattice corneal dystrophy of the cornea with hereditary generalized amyloidosis. Ophthalmologica 1979; 178: 173-80.
5. Kiuru S. Familial amyloidosis of the Finnish type (FAF). A clinical study of 30 patients. Acta Neurol Scand 1992; 86: 346-53.
6. Kivela T, Tarkkanen A, Frangione B, et al. Ocular amyloid deposition in familial amyloidosis, Finnish: an analysis of native and variant gelsolin in Meretoja's syndrome. Invest Ophthalmol Vis Sci 1994; 35: 3759-69.
7. Rosenberg ME, Tervo TMT, Gallar J, et al. Corneal morphology and sensitivity in lattice dystrophy type II (familial amyloidosis, Finnish type). Invest Ophthalmol Vis Sci 2001; 42: 634-41.
8. Klaus E, Freiberger E, Kavka G, Vodicka F. Familiares vorkommen von bulbärparalitischer mit grittiger Hornhautdystrophie und Cutis hyperelastica bei drei Schwestern. Psychiatr Neurol (Basel) 1959; 138: 79-97.
9. Boysen G, Galassi G, Kamieniecka Z, et al. Familial amyloidosis with cranial neuropathy and lattice corneal dystrophy. J Neurol Neurosurg Psychiatry 1979; 42: 1020-30.
10. Starck T, Kenyon KR, Hanninen LA, et al. Clinical and histopathologic studies of two families with lattice corneal dystrophy and familial systemic amyloidosis (Meretoja syndrome). Ophthalmology 1991; 98: 1197-206.
11. Sunada Y, Shimizu T, Nakase H, et al. Inherited amyloid polyneuropathy type IV (gelsolin variant) in a Japanese family. Ann Neurol 1993; 33: 57-62.
12. de la Chapelle A, Tolvanen R, Boysen G, et al. Gelsolin-derived familial amyloidosis caused by asparagine or tyrosine substitution for aspartic acid at residue 187. Nat Genet 1992; 2: 157-60.
13. Akiya S, Nishio Y, Ibi K, et al. Lattice corneal dystrophy type II associated with familial amyloid polyneuropathy type IV. Ophthalmology 1996; 103: 1106-10.
14. Stewart HS, Parveen R, Ridgway AE, Bonshek R, Black GCM. Late onset lattice corneal dystrophy with systemic familial amyloidosis, amyloidosis V, in an English family. Br J Ophthalmol 2000; 84: 390-4.
15. Rothstein A, Auran JD, Wittpenn JR, Koester CJ, Florakis GJ. Confocal microscopy in Meretoja syndrome. Cornea 2002; 21: 364-7.
16. Afshari NA, Mullally JE, Afshari MA, et al. Survey of patients with granular, lattice, Avellino, and Reis-Bücklers corneal dystrophies for mutations in the BIGH3 and gelsolin genes. Arch Ophthalmol 2001; 119: 16-22.
17. Kiuru S. Gelsolin-related familial amyloidosis, Finnish type (FAF) and its variants found worldwide. Amyloid Int J Exp Clin Invest 1998; 5: 55-66.
18. Meretoja J, Tarkkanen A. Pseudoexfoliation syndrome in familial systemic amyloidosis with lattice corneal dystrophy. Ophthalmic Res 1975; 7: 194-200.
19. Fernandez AL, Herreros JM, Monzonis AM, Panizo A. Heart transplantation for Finnish type familial systemic amyloidosis. Scand Cardiovasc J 1997; 31: 357-9.
20. Meretoja J, Jokinen EJ, Collan Y, Lahdevirta J. Renal biopsy findings in familial amyloidosis with corneal lattice dystrophy. An immuno-histochemical, light-microscopical and electron-microscopical study. Acta Pathol Microbiol Scand A 1972; 233 (Suppl 233): 228-38.
21. Meretoja J. Comparative histopathological and clinical findings in eyes with lattice corneal dystrophy of two different types. Ophthalmologica 1972; 165: 15-37.